Clinical utility of anti‐cytosolic 5’‐nucleotidase 1A antibody in idiopathic inflammatory myopathies
Abstract Objective To define the clinicopathologic features and diagnostic utility associated with anti‐cytosolic 5′‐nucleotidase 1A (NT5C1A) antibody seropositivity in idiopathic inflammatory myopathies (IIMs). Methods Anti‐NT5C1A antibody status was clinically tested between 2014 and 2019 in the W...
Main Authors: | Chiseko Ikenaga, Andrew R. Findlay, Namita A. Goyal, Sarah Robinson, Jonathan Cauchi, Yessar Hussain, Leo H. Wang, Joshua C. Kershen, Brent A. Beson, Michael Wallendorf, Robert C. Bucelli, Tahseen Mozaffar, Alan Pestronk, Conrad C. Weihl |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-03-01
|
Series: | Annals of Clinical and Translational Neurology |
Online Access: | https://doi.org/10.1002/acn3.51294 |
Similar Items
-
The properties and physiological role of the cytosolic 5'-nucleotidase
by: Worku, Y.
Published: (1984) -
Phenotypic diversity in an international Cure VCP Disease registry
by: Chiseko Ikenaga, et al.
Published: (2020-09-01) -
Client processing is altered by novel myopathy-causing mutations in the HSP40 J domain.
by: Melanie Y Pullen, et al.
Published: (2020-01-01) -
Evidence for a Cross-Talk Between Cytosolic 5′-Nucleotidases and AMP-Activated Protein Kinase
by: Marcella Camici, et al.
Published: (2020-12-01) -
Autoantibodies to Cytosolic 5′-Nucleotidase 1A in Primary Sjögren’s Syndrome and Systemic Lupus Erythematosus
by: Anke Rietveld, et al.
Published: (2018-06-01)